Innovax ™-ND (live cell frozen vaccine against Marek’s disease and avian infectious laryngotracheitis)
Ingredients: one dose of the vaccine contains at least 2248 BTO of live recombinant turkey herpesvirus strain HVT / ILT-138 serotype 3 composed of genes of infectious laryngotracheitis virus. The vaccine contains Gentamycin residues.
Pharmaceutical form: frozen cell suspension.
Method of administration and dosage: administer 0.2 ml of the product per head subcutaneously in the neck area. Inovo vaccine is injected on the 18th day of embryo development at a dose of 0.05 ml / egg.
Packaging: sealed cryogenic type I glass vials (according to the European Pharmacopoeia) containing a cell suspension of 1,000, 2,000, 3,000, 4,000 or 5,000 doses of the vaccine. Nobilis® Diluent CA solvent: polyethylene bags (accroding to European Pharmacopoeia) of 200, 400, 500, 600, 800, 1000 and 1200 ml, sealed with rubber stopper and cap. Type II hydrolytic glass vials of 200, 400 and 500 ml (according to the European Pharmacopoeia) with rubber stoppers and flip off aluminum caps.
Storage and transportation conditions: Vials to be stored in a container with liquid nitrogen.
Solvent to be stored at room temperature (15-25 ºС).
Containers to be stored in a clean, dry place, in an upright position in a well ventilated room, separated from the incubation and poultry house.